|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.73 USD | -4.79% |
|
+4.89% | +3.31% |
| 07-12 | Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug | MT |
| 07-10 | Health Care Down on Rotation Back to Tech - Health Care Roundup | DJ |
| Market Cap | 3,945B 24.75B 21.52B 20.03B 18.39B 34.73B 2,363B 35.27B 236B 92.66B 1,176B 92.97B 90.93B | P/E 2027 * |
11.5x | P/E 2028 * | 11.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3,815B 23.94B 20.81B 19.37B 17.78B 33.58B 2,285B 34.1B 228B 89.61B 1,138B 89.9B 87.93B | EV / Sales 2027 * |
1.69x | EV / Sales 2028 * | 1.67x |
| Free-Float |
97.66% | Yield 2027 * |
3.65% | Yield 2028 * | 3.77% |
Last Transcript: Astellas Pharma Inc.
| 1 day | -4.79% | ||
| 1 week | +4.89% | ||
| Current month | +2.69% | ||
| 1 month | +2.69% | ||
| 3 months | -3.99% | ||
| 6 months | -0.94% | ||
| Current year | +3.31% |
| 1 week | 13.37 |  | 14.47 |
| 1 month | 13.03 | | 14.47 |
| Current year | 12.82 | | 17.35 |
| 1 year | 10.03 | | 17.35 |
| 3 years | 8.37 | | 17.35 |
| 5 years | 8.37 | | 18.18 |
| 10 years | 8.37 | | 18.46 |
| Manager | Title | Age | Since |
|---|---|---|---|
Naoki Okamura
CEO | Chief Executive Officer | 63 | 2023-02-09 |
Kitamura Atsushi
DFI | Director of Finance/CFO | 54 | 2023-10-31 |
Tatjana Dragovic
CMP | Compliance Officer | - | 2025-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kenji Yasukawa
CHM | Chairman | 66 | 2023-02-09 |
Naoki Okamura
BRD | Director/Board Member | 63 | 2019-05-31 |
| Director/Board Member | 58 | 2023-05-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.79% | +4.89% | - | - | 25.7B | |
| -0.53% | -3.12% | +51.15% | +150.58% | 1,030B | |
| +0.21% | -1.13% | +53.26% | +46.92% | 617B | |
| -2.51% | -2.33% | +32.56% | +66.35% | 455B | |
| +0.06% | +1.17% | +36.21% | +31.25% | 350B | |
| -0.14% | -0.83% | +33.24% | +40.28% | 299B | |
| -0.69% | -0.44% | +9.86% | +14.23% | 265B | |
| -7.37% | -4.31% | -5.69% | -41.99% | 225B | |
| -0.64% | +3.68% | +27.80% | +62.95% | 209B | |
| -0.82% | -0.50% | +13.46% | +69.41% | 163B | |
| Average | -1.33% | +4.83% | +27.98% | +48.89% | 401.41B | |
| Weighted average by Cap. | -0.45% | +4.87% | +36.61% | +70.85% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 2,260B 14.18B 12.33B 11.47B 10.53B 19.89B 1,354B 20.2B 135B 53.07B 674B 53.25B 52.08B | 2,079B 13.05B 11.34B 10.56B 9.69B 18.3B 1,245B 18.59B 124B 48.83B 620B 49B 47.92B |
| Net income | 343B 2.15B 1.87B 1.74B 1.6B 3.02B 205B 3.06B 20.5B 8.05B 102B 8.07B 7.9B | 331B 2.08B 1.8B 1.68B 1.54B 2.91B 198B 2.96B 19.8B 7.77B 98.64B 7.8B 7.62B |
| Net Debt | -130B -816M -710M -660M -606M -1.15B -77.92B -1.16B -7.78B -3.06B -38.79B -3.07B -3B | -472B -2.96B -2.58B -2.4B -2.2B -4.16B -283B -4.22B -28.27B -11.09B -141B -11.13B -10.89B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$13.73 | -4.79% | 147,959 |
| 26-07-30 | US$14.42 | +3.37% | 124,999 |
| 26-07-29 | US$13.95 | +2.20% | 77,611 |
| 26-07-28 | US$13.65 | +1.78% | 130,246 |
| 26-07-27 | US$13.41 | +1.56% | 175,779 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4503 Stock
- ALPMY Stock
Select your edition
All financial news and data tailored to specific country editions
